<!DOCTYPE html>


<html theme="dark" showBanner="true" hasBanner="false" > 
<link href="https://cdn.staticfile.org/font-awesome/6.4.2/css/fontawesome.min.css" rel="stylesheet">
<link href="https://cdn.staticfile.org/font-awesome/6.4.2/css/brands.min.css" rel="stylesheet">
<link href="https://cdn.staticfile.org/font-awesome/6.4.2/css/solid.min.css" rel="stylesheet">
<script src="/js/color.global.min.js" ></script>
<script src="/js/load-settings.js" ></script>
<head>
  <meta charset="utf-8">
  
  
  
<!-- Gaug.es Analytics -->
<script>
  var _gauges = _gauges || [];
  (function() {
    var t   = document.createElement('script');
    t.async = true;
    t.id    = 'gauges-tracker';
    t.setAttribute('data-site-id', 'true');
    t.setAttribute('data-track-path', 'https://track.gaug.es/track.gif');
    t.src = 'https://d36ee2fcip1434.cloudfront.net/track.js';
    var s = document.getElementsByTagName('script')[0];
    s.parentNode.insertBefore(t, s);
  })();
</script>
<!-- End Gaug.es Analytics -->


  
  <title>Antitrustia连锁医院的反竞争行为 | Hexo</title>
  <meta name="viewport" content="width=device-width, initial-scale=1, shrink-to-fit=no">

  <link rel="preload" href="/css/fonts/Roboto-Regular.ttf" as="font" type="font/ttf" crossorigin="anonymous">
  <link rel="preload" href="/css/fonts/Roboto-Bold.ttf" as="font" type="font/ttf" crossorigin="anonymous">

  <meta name="description" content="虚拟案例分析">
<meta property="og:type" content="article">
<meta property="og:title" content="Antitrustia连锁医院的反竞争行为">
<meta property="og:url" content="http://example.com/2024/11/24/%E7%AB%9E%E4%BA%89%E6%B3%95/index.html">
<meta property="og:site_name" content="Hexo">
<meta property="og:description" content="虚拟案例分析">
<meta property="og:locale" content="en_US">
<meta property="og:image" content="http://example.com/images/UNCITRAL.png">
<meta property="article:published_time" content="2024-11-23T16:00:00.000Z">
<meta property="article:modified_time" content="2024-11-26T08:00:33.190Z">
<meta property="article:author" content="John Doe">
<meta property="article:tag" content="INTERNATIONAL">
<meta property="article:tag" content="ANTITRUST">
<meta name="twitter:card" content="summary">
<meta name="twitter:image" content="http://example.com/images/UNCITRAL.png">
  
    <link rel="alternate" href="/atom.xml" title="Hexo" type="application/atom+xml">
  
  
    <link rel="icon" media="(prefers-color-scheme: light)" href="/images/favicon-light-32.png" sizes="32x32">
    <link rel="icon" media="(prefers-color-scheme: light)" href="/images/favicon-light-128.png" sizes="128x128">
    <link rel="icon" media="(prefers-color-scheme: light)" href="/images/favicon-light-180.png" sizes="180x180">
    <link rel="icon" media="(prefers-color-scheme: light)" href="/images/favicon-light-192.png" sizes="192x192">
    <link rel="icon" media="(prefers-color-scheme: dark)" href="/images/favicon-dark-32.png" sizes="32x32">
    <link rel="icon" media="(prefers-color-scheme: dark)" href="/images/favicon-dark-128.png" sizes="128x128">
    <link rel="icon" media="(prefers-color-scheme: dark)" href="/images/favicon-dark-180.png" sizes="180x180">
    <link rel="icon" media="(prefers-color-scheme: dark)" href="/images/favicon-dark-192.png" sizes="192x192">
  
  
  
<link rel="stylesheet" href="/css/style.css">

<meta name="generator" content="Hexo 7.3.0"></head>

<body>
  
   
  <div id="main-grid" class="  ">
    <div id="nav" class=""  >
      <navbar id="navbar">
  <nav id="title-nav">
    <a href="/">
      <div id="vivia-logo">
        <div class="dot"></div>
        <div class="dot"></div>
        <div class="dot"></div>
        <div class="dot"></div>
      </div>
      <div>Hexo </div>
    </a>
  </nav>
  <nav id="main-nav">
    
      <a class="main-nav-link" href="/">Home</a>
    
      <a class="main-nav-link" href="/archives">Archives</a>
    
      <a class="main-nav-link" href="/about">About</a>
    
  </nav>
  <nav id="sub-nav">
    <a id="theme-btn" class="nav-icon">
      <span class="light-mode-icon"><svg xmlns="http://www.w3.org/2000/svg" height="20" viewBox="0 -960 960 960" width="20"><path d="M438.5-829.913v-48q0-17.452 11.963-29.476 11.964-12.024 29.326-12.024 17.363 0 29.537 12.024t12.174 29.476v48q0 17.452-11.963 29.476-11.964 12.024-29.326 12.024-17.363 0-29.537-12.024T438.5-829.913Zm0 747.826v-48q0-17.452 11.963-29.476 11.964-12.024 29.326-12.024 17.363 0 29.537 12.024t12.174 29.476v48q0 17.452-11.963 29.476-11.964 12.024-29.326 12.024-17.363 0-29.537-12.024T438.5-82.087ZM877.913-438.5h-48q-17.452 0-29.476-11.963-12.024-11.964-12.024-29.326 0-17.363 12.024-29.537t29.476-12.174h48q17.452 0 29.476 11.963 12.024 11.964 12.024 29.326 0 17.363-12.024 29.537T877.913-438.5Zm-747.826 0h-48q-17.452 0-29.476-11.963-12.024-11.964-12.024-29.326 0-17.363 12.024-29.537T82.087-521.5h48q17.452 0 29.476 11.963 12.024 11.964 12.024 29.326 0 17.363-12.024 29.537T130.087-438.5Zm660.174-290.87-34.239 32q-12.913 12.674-29.565 12.174-16.653-.5-29.327-13.174-12.674-12.673-12.554-28.826.12-16.152 12.794-28.826l33-35q12.913-12.674 30.454-12.674t30.163 12.847q12.709 12.846 12.328 30.826-.38 17.98-13.054 30.653ZM262.63-203.978l-32 34q-12.913 12.674-30.454 12.674t-30.163-12.847q-12.709-12.846-12.328-30.826.38-17.98 13.054-30.653l33.239-31q12.913-12.674 29.565-12.174 16.653.5 29.327 13.174 12.674 12.673 12.554 28.826-.12 16.152-12.794 28.826Zm466.74 33.239-32-33.239q-12.674-12.913-12.174-29.565.5-16.653 13.174-29.327 12.673-12.674 28.826-13.054 16.152-.38 28.826 12.294l35 33q12.674 12.913 12.674 30.454t-12.847 30.163q-12.846 12.709-30.826 12.328-17.98-.38-30.653-13.054ZM203.978-697.37l-34-33q-12.674-12.913-13.174-29.945-.5-17.033 12.174-29.707t31.326-13.293q18.653-.62 31.326 13.054l32 34.239q11.674 12.913 11.174 29.565-.5 16.653-13.174 29.327-12.673 12.674-28.826 12.554-16.152-.12-28.826-12.794ZM480-240q-100 0-170-70t-70-170q0-100 70-170t170-70q100 0 170 70t70 170q0 100-70 170t-170 70Zm-.247-82q65.703 0 111.475-46.272Q637-414.544 637-480.247t-45.525-111.228Q545.95-637 480.247-637t-111.475 45.525Q323-545.95 323-480.247t45.525 111.975Q414.05-322 479.753-322ZM481-481Z"/></svg></span>
      <span class="dark-mode-icon"><svg xmlns="http://www.w3.org/2000/svg" height="20" viewBox="0 -960 960 960" width="20"><path d="M480.239-116.413q-152.63 0-258.228-105.478Q116.413-327.37 116.413-480q0-130.935 77.739-227.435t206.304-125.043q43.022-9.631 63.87 10.869t3.478 62.805q-8.891 22.043-14.315 44.463-5.424 22.42-5.424 46.689 0 91.694 64.326 155.879 64.325 64.186 156.218 64.186 24.369 0 46.978-4.946 22.609-4.945 44.413-14.076 42.826-17.369 62.967 1.142 20.142 18.511 10.511 61.054Q807.174-280 712.63-198.206q-94.543 81.793-232.391 81.793Zm0-95q79.783 0 143.337-40.217 63.554-40.218 95.793-108.283-15.608 4.044-31.097 5.326-15.49 1.283-31.859.805-123.706-4.066-210.777-90.539-87.071-86.473-91.614-212.092-.24-16.369.923-31.978 1.164-15.609 5.446-30.978-67.826 32.478-108.282 96.152Q211.652-559.543 211.652-480q0 111.929 78.329 190.258 78.329 78.329 190.258 78.329ZM466.13-465.891Z"/></svg></span>
    </a>
    
      <a id="nav-rss-link" class="nav-icon mobile-hide" href="/atom.xml" title="RSS Feed">
        <svg xmlns="http://www.w3.org/2000/svg" height="20" viewBox="0 -960 960 960" width="20"><path d="M198-120q-25.846 0-44.23-18.384-18.384-18.385-18.384-44.23 0-25.846 18.384-44.23 18.384-18.385 44.23-18.385 25.846 0 44.23 18.385 18.384 18.384 18.384 44.23 0 25.845-18.384 44.23Q223.846-120 198-120Zm538.385 0q-18.846 0-32.923-13.769-14.076-13.769-15.922-33.23-8.692-100.616-51.077-188.654-42.385-88.039-109.885-155.539-67.5-67.501-155.539-109.885Q283-663.462 182.385-672.154q-19.461-1.846-33.23-16.23-13.769-14.385-13.769-33.846t14.076-32.922q14.077-13.461 32.923-12.23 120.076 8.692 226.038 58.768 105.961 50.077 185.73 129.846 79.769 79.769 129.846 185.731 50.077 105.961 58.769 226.038 1.231 18.846-12.538 32.922Q756.461-120 736.385-120Zm-252 0q-18.231 0-32.423-13.461t-18.653-33.538Q418.155-264.23 348.886-333.5q-69.27-69.27-166.501-84.423-20.077-4.462-33.538-18.961-13.461-14.5-13.461-33.346 0-19.076 13.884-33.23 13.884-14.153 33.115-10.922 136.769 15.384 234.384 112.999 97.615 97.615 112.999 234.384 3.231 19.23-10.538 33.115Q505.461-120 484.385-120Z"/></svg>
      </a>
    
    <div id="nav-menu-btn" class="nav-icon">
      <svg xmlns="http://www.w3.org/2000/svg" height="20" viewBox="0 -960 960 960" width="20"><path d="M177.37-252.282q-17.453 0-29.477-11.964-12.024-11.963-12.024-29.326t12.024-29.537q12.024-12.174 29.477-12.174h605.26q17.453 0 29.477 11.964 12.024 11.963 12.024 29.326t-12.024 29.537q-12.024 12.174-29.477 12.174H177.37Zm0-186.218q-17.453 0-29.477-11.963-12.024-11.964-12.024-29.326 0-17.363 12.024-29.537T177.37-521.5h605.26q17.453 0 29.477 11.963 12.024 11.964 12.024 29.326 0 17.363-12.024 29.537T782.63-438.5H177.37Zm0-186.217q-17.453 0-29.477-11.964-12.024-11.963-12.024-29.326t12.024-29.537q12.024-12.174 29.477-12.174h605.26q17.453 0 29.477 11.964 12.024 11.963 12.024 29.326t-12.024 29.537q-12.024 12.174-29.477 12.174H177.37Z"/></svg>
    </div>
  </nav>
</navbar>
<div id="nav-dropdown" class="hidden">
  <div id="dropdown-link-list">
    
      <a class="nav-dropdown-link" href="/">Home</a>
    
      <a class="nav-dropdown-link" href="/archives">Archives</a>
    
      <a class="nav-dropdown-link" href="/about">About</a>
    
    
      <a class="nav-dropdown-link" href="/atom.xml" title="RSS Feed">RSS</a>
     
    </div>
</div>
<script>
  let dropdownBtn = document.getElementById("nav-menu-btn");
  let dropdownEle = document.getElementById("nav-dropdown");
  dropdownBtn.onclick = function() {
    dropdownEle.classList.toggle("hidden");
  }
</script>
    </div>
    <div id="sidebar-wrapper">
      <sidebar id="sidebar">
  
    <div class="widget-wrap">
  <div class="info-card">
    <div class="avatar">
      
        <image src=/images/avatar.jpg></image>
      
      <div class="img-dim"></div>
    </div>
    <div class="info">
      <div class="username">雪糕君 </div>
      <div class="dot"></div>
      <div class="subtitle">SJTU double bachelor's degree in Law and Economics; HKU ADR LLM </div>
      <div class="link-list">
        
          <a class="link-btn" target="_blank" rel="noopener" href="https://mp.weixin.qq.com/mp/appmsgalbum?__biz=Mzk0MTEyODUyMA==&action=getalbum&album_id=2537255885711048705&subscene=126&scenenote=https%3A%2F%2Fmp.weixin.qq.com%2Fs%3F__biz%3DMzk0MTEyODUyMA%3D%3D%26mid%3D2247486101%26idx%3D1%26sn%3D6a43e57a3abd6382261e8cd5156ca7b6%26chksm%3Dc3098ac24893f702dabbbdb992a3f96a3277eed8b2375f67d067df0fd67662bbd3f82ed0f973%26scene%3D126%26sessionid%3D1730190028%26subscene%3D227%26clicktime%3D1730190033%26enterid%3D1730190033%26key%3Ddaf9bdc5abc4e8d07f0422f6e7f96cdcd6f23cb2968f228deaa4f763f6aca3ef9649f0553f639257a958c897689ae42b1d90846f53fb61d9fc55bef072cb5d19900662828c0df74f06dcead039fa5fa68ae7cf8be1915bd37e4497cdd6b212a065e2b4261f8a96dfcb5dcd52a4b327a6f8f61b41dc2d102497860435a01b7b6f%26ascene%3D0%26uin%3DMTg1MTEyNzY3NA%253D%253D%26devicetype%3DWindows%2B11%2Bx64%26version%3D63090c11%26lang%3Dzh_CN%26countrycode%3DCN%26exportkey%3Dn_ChQIAhIQCk93BtxjuaL6c%252BGspMb0sRLmAQIE97dBBAEAAAAAAJwmGFMQgGsAAAAOpnltbLcz9gKNyK89dVj0mOz8JelrRBwzgBHHK5uKvbZNISqkP2q6LXB%252BS9Ku49h0QJOJnSUw1SpLqgac5ohL9Slq8YvUcuHqY5aGjzgqIhO4aAcTkS%252BlN39KA%252B5CjDEHaPhGLB8Ez8trXzMYqgyEn5oYgm54k%252FsdLtVthoNDcI0U83ORs1yJORk2sTgJCD%252BuLGh1Uf91VUs%252FxfADbz0CCysSqj8bpCnODMee9LP6fY0Bx2vt%252FTd2hbj1hHRxXRv75C2iV8Ff8jRPDU9VMC%252FZ%26acctmode%3D0%26pass_ticket%3DE2oQMSCabSWCZrwrdEdTnZciclf2aRNoFU06jS%252B8jYm2l%252B29AoN5kUGKAvL5SJ4w%26wx_header%3D1%26fasttmpl_type%3D0%26fasttmpl_fullversion%3D7446448-zh_CN-zip%26fasttmpl_flag%3D1&nolastread=1#wechat_redirect" title="公众号"><i class="fa-solid fa-file"></i></a>
        
          <a class="link-btn" target="_blank" rel="noopener" href="https://www.instagram.com/migaosama0211/" title="Instagram"><i class="fa-brands fa-instagram"></i></a>
        
          <a class="link-btn" target="_blank" rel="noopener" href="https://weibo.com/u/6409598688" title="Weibo"><i class="fa-brands fa-weibo"></i></a>
         
      </div>  
    </div>
  </div>
</div>

  
  <div class="sticky">
    
      


  <div class="widget-wrap">
    <div class="widget">
      <h3 class="widget-title">Categories</h3>
      <div class="category-box">
            <a class="category-link" href="/categories/LAW/">
                LAW
                <div class="category-count">8</div>
            </a>
        
            <a class="category-link" href="/categories/READING/">
                READING
                <div class="category-count">1</div>
            </a>
        </div>
    </div>
  </div>


    
      
  <div class="widget-wrap">
    <div class="widget">
      <h3 class="widget-title">Tags</h3>
      <ul class="widget-tag-list" itemprop="keywords"><li class="widget-tag-list-item"><a class="widget-tag-list-link" href="/tags/ANTITRUST/" rel="tag">ANTITRUST</a></li><li class="widget-tag-list-item"><a class="widget-tag-list-link" href="/tags/INTERNATIONAL/" rel="tag">INTERNATIONAL</a></li><li class="widget-tag-list-item"><a class="widget-tag-list-link" href="/tags/ISRAEL/" rel="tag">ISRAEL</a></li><li class="widget-tag-list-item"><a class="widget-tag-list-link" href="/tags/LABOR-LAW/" rel="tag">LABOR LAW</a></li><li class="widget-tag-list-item"><a class="widget-tag-list-link" href="/tags/MEDIATION/" rel="tag">MEDIATION</a></li><li class="widget-tag-list-item"><a class="widget-tag-list-link" href="/tags/PHILOSOPHY/" rel="tag">PHILOSOPHY</a></li><li class="widget-tag-list-item"><a class="widget-tag-list-link" href="/tags/SOCIOLOGY/" rel="tag">SOCIOLOGY</a></li></ul>
    </div>
  </div>


    
  </div>
</sidebar>
    </div>
    <div id="content-body">
       


<article id="post-竞争法" class="h-entry article article-type-post" itemprop="blogPost" itemscope itemtype="https://schema.org/BlogPosting">
  
    
<div class="article-gallery">
  <div class="article-gallery-photos">
    
      <a class="article-gallery-img" rel="gallery_cm3xyasdg00003oifar0w3kwo">
        <img src="/images/UNCITRAL.png" itemprop="image">
      </a>
    
  </div>
</div>

   
  <div class="article-inner">
    <div class="article-main">
      <header class="article-header">
        
<div class="main-title-bar">
  <div class="main-title-dot"></div>
  
    
      <h1 class="p-name article-title" itemprop="headline name">
        Antitrustia连锁医院的反竞争行为
      </h1>
    
  
</div>

        <div class='meta-info-bar'>
          <div class="meta-info">
  <time class="dt-published" datetime="2024-11-23T16:00:00.000Z" itemprop="datePublished">2024-11-24</time>
</div>
          <div class="need-seperator meta-info">
            <div class="meta-cate-flex">
  
  <a class="meta-cate-link" href="/categories/LAW/">LAW</a>
   
</div>
  
          </div>
          <div class="wordcount need-seperator meta-info">
            9.3k words 
          </div>
        </div>
        
  <ul class="article-tag-list" itemprop="keywords"><li class="article-tag-list-item"><a class="article-tag-list-link" href="/tags/ANTITRUST/" rel="tag">ANTITRUST</a></li><li class="article-tag-list-item"><a class="article-tag-list-link" href="/tags/INTERNATIONAL/" rel="tag">INTERNATIONAL</a></li></ul>

      </header>
      <div class="e-content article-entry" itemprop="articleBody">
        
          <h2 id="案件事实"><a href="#案件事实" class="headerlink" title="案件事实"></a>案件事实</h2><p>There are four major hospital chains in Antitrustia, Alpha, Beta, Gamma, and Delta.  They account for 30%, 25%, 15% and 10% of the hospital beds in Antitrustia  respectively. </p>
<p>Hospital services can be divided into primary and secondary care,  which consists of common medical services like setting a broken bone and  performing a tonsillectomy. Tertiary care involves more advanced and critical  services such as invasive cardiovascular surgery and intensive neonatal care. If  market share is calculated for each kind of care, the four hospital chains account  for 40%, 25%, 10% and 5% of the revenue generated in the most recent year from  primary and secondary care services and 10%, 20%, 15%, and 35% of the revenue  generated in the most recent year from tertiary care services. In other words,  Alpha tends to focus on primary and secondary care while Delta specializes in  tertiary care services.  </p>
<p>There is a shortage of nurses in Antitrustia and thus the hospitals need to bring in  foreign nurses, most of whom come from Shermania. The hospitals use  employment agencies to help them recruit foreign nurses. These agencies charge  a referral fee of $10,000 for every nurse who completes a two-year contract. For  nurses that do not complete a two-year contract, the hospitals would receive a  rebate of the referral fees. The four hospital chains believe that this referral fee is  excessive and thus agree to bargain collectively with these agencies. </p>
<p>These  agencies did not always charge such high fees. It was in light of the surging  demand for nurses in Antitrustia in recent years that the referral fee skyrocketed.  Starting in 2021, the largest agency would first make a public announcement  about increases in referral fees even though these fees were historically  negotiated bilaterally between the agencies and the hospitals. Following the  announcement, the other agencies would follow suit and announce the same  increase in fees. As a result, referral fees have increased annually by 15% since  2021. </p>
<p>However, there is evidence that not every agency follows the same pattern  of fee increases. Some agencies would increase the referral fees by a smaller  amount and some would not increase the fees at all.   In response to the precipitous fee increase, the hospitals agree on the following  proposals: (1) nurses will not be offered a contract for more than 18 months; (2)  agencies will need to offer a rebate of 10% of the referral fees for every 100 nurses  hired, which is to be calculated across all four hospital chains as opposed to on a  chain-by-chain basis; and (3) agencies will need to cover the expenses incurred in  obtaining the valid employment visa for these nurses. Previously, the hospitals  would be responsible for the visa expenses. The agencies are shocked by these  proposals and agree to negotiate as a group with the hospitals to increase their  bargaining power. </p>
<p>In response, the hospitals announce that they would only  negotiate with each agency on an individual basis and would offer a 10% bonus to  the first three agencies that break ranks with the other agencies. The agencies’  collective bargaining effort immediately unravels.  Demand for nurses continues to surge. In order to secure a sufficient number of  nurses, Alpha, Beta, Gamma and Delta agree to raise the salary they offer to new  nurses by 30%. As a result, the remaining hospital chains in Antitrustia begin to  experience difficulty in recruitment. There is evidence that the shortage of nurses  has caused the quality of service at other hospitals to suffer and patients have  begun to complain. Some of them have even stopped going to the affected  hospitals.   </p>
<p>The hospitals purchase their medicines from wholesalers known as pharmacy  benefits managers. Alpha and Beta have historically met most of their medicinal  needs from PBMA, the largest pharmacy benefits manager in Antitrustia, which  has a 60% market share, while Gamma and Delta have tended to spread their  purchases across multiple pharmacy benefits managers. PBMA has decided to  enter the medical devices business and has started to supply devices such as stents  and catheters and prothetics. However, the market is currently dominated by  Medical Devices, Inc. and PBMA struggles to make inroads into the market. </p>
<p>To  increase its competitiveness in the market, PBMA decides to introduce a rebate  scheme for all its products. Customers which purchase more than 80% of their  medical device needs from PBMA would receive a rebate of 10% across all the  products they obtain from PBMA, including medicines and medical devices.  However, prior to the introduction of the scheme, PBMA has first increased the  prices of its medicines by 15%.   </p>
<p>Most of the patients who use the hospitals’ services are covered by insurance. The  insurers reimburse the hospitals for the services provided by the hospitals.  Negotiation for the reimbursement amount is done on a case-by-case basis with  the hospitals and the insurers forming a review committee to review the medical  necessity of the treatment. The insurers find the current arrangement  cumbersome and propose an alternative arrangement to the hospitals. </p>
<p>As  opposed to negotiating individual reimbursements, the insurers offer to pay a  lump sum for every 100 patients treated for a certain condition, such as lung  cancer. The insurers believe that some patients cost more to treat while others  cost less. If the lump sum covers the median expense for each patient, it would  suffice. The insurers request an additional mechanism to claw back excess  reimbursement. If there is evidence that over 60% of a particular batch of patients  cost less than the median cost to treat, the insurers can request a reduction in the  reimbursement amount. The lump sum reimbursement thus represents a cap on  maximum reimbursement. The insurers argue that this scheme gives them  predictability in reimbursement amounts, which helps them set the insurance  premium more accurately. </p>
<p>However, there is evidence that following the  introduction of this scheme, hospitals have raised their charges for services  rendered to uninsured patients.   Hospitals are a cut-throat business and profitability very much depends on  utilization rate. Therefore, hospitals have a significant incentive to maximize  utilization. </p>
<p>One of the ways to do that is through advertising. Because most  patients do not pay their hospital expenses out of pocket, advertising discounts to  patients is unlikely to attract them. Therefore, hospitals focus on impressing  patients with the quality of their services. Beta and Gamma have launched an  advertising campaign emphasizing that they provide high quality of care. Delta  opts for a more precise approach that focuses on measurable criteria such as  nurse-to-patient ratio, and success rate and survival rate for each type of condition.  These quantitative indicators have all been verified by independent auditors and  are published in Delta’s annual report. While Beta and Gamma do not manage to  attract many additional patients, Delta’s promotional campaign is a huge success  and patient admission rate increases by 15%. </p>
<p>After this, the Antitrustia Hospital  Association (“AHA”), the trade association for hospitals in Antitrustia, adopts a  new rule banning all quality advertising on the grounds that such advertising is  inherently unverifiable. In addition, Alpha and Gamma begin to offer rebates of 30% of the surgical fees  paid by patients to surgeons who choose to operate in their hospitals so long as  they prescribe the hospitals’ in-house anesthesiologists for their patients.  Previously patients often chose their own anesthesiologists upon their surgeons’  recommendations. As a result, surgeons begin to charge their patients an  additional fee of 30% if the patients wanted to choose their own anesthesiologists. </p>
<h2 id="思路"><a href="#思路" class="headerlink" title="思路"></a>思路</h2><table>
<thead>
<tr>
<th>思考方向</th>
<th>对应的事实</th>
</tr>
</thead>
<tbody><tr>
<td><strong>市场定义与市场力量</strong></td>
<td>“Alpha, Beta, Gamma, 和 Delta 这四大医院连锁机构分别占据Antitrustia医院床位的30%, 25%, 15%, 和 10%… 在初级和次级护理市场的收入占比为40%, 25%, 10%, 和 5%… 而在三级护理市场的收入占比为10%, 20%, 15%, 和 35%.”</td>
</tr>
<tr>
<td><strong>合谋行为与价格操控</strong></td>
<td>“四大医院连锁机构认为推荐费过高，决定集体与中介机构谈判… 这些中介机构同意作为一个团体与医院协商以增加议价能力… 医院宣布他们将只与个别代理机构谈判，并向前三个打破协议的代理机构提供10%的奖金。”</td>
</tr>
<tr>
<td><strong>独占交易(Exclusive Dealing)与排他性行为</strong></td>
<td>“医院使用中介帮助招聘外国护士…中介机构收取每名护士完成两年合同的推荐费为$10,000…医院认为该推荐费过高，决定集体谈判。”</td>
</tr>
<tr>
<td><strong>共谋行为(Collusion)</strong></td>
<td>“医院同意提高新护士的薪水30%，导致其他医院在招聘上处于劣势。”</td>
</tr>
<tr>
<td><strong>纵向整合与优惠折扣(Vertical Integration and Preferential Rebate)</strong></td>
<td>“Alpha和Beta 用于大部分药品采购的 PBMA推出了一个回扣计划…在引入该计划之前，PBMA先将药品价格提高了15%。”</td>
</tr>
<tr>
<td><strong>集体协商与定价(Collective Bargaining and Pricing)</strong></td>
<td>“保险公司提议对特定病症患者支付总额而不是单个患者谈判…医院为未投保患者的服务增加收费。”</td>
</tr>
<tr>
<td><strong>广告限制与反竞争行为(Advertising Restriction and Anti-Competitive Practices)</strong></td>
<td>“Antitrustia医院协会（AHA）采用了一项新规则，禁止所有质量广告。它们认为这种广告本质上是无法验证的。”</td>
</tr>
<tr>
<td><strong>回扣与关联销售(Rebates and Tied Selling)</strong></td>
<td>“Alpha和Gamma向手术费用提供30%的回扣，前提是他们使用医院的麻醉师…结果，外科医生对患者额外收费30%以便患者选择自己的麻醉师。”</td>
</tr>
</tbody></table>
<h2 id="1-市场定义与市场力量"><a href="#1-市场定义与市场力量" class="headerlink" title="1. 市场定义与市场力量"></a>1. <strong>市场定义与市场力量</strong></h2><p>美国联邦反垄断机构（FTC和DOJ）或私人原告试图在民事反垄断案件中胜诉时，必须“证明对竞争过程，也就是对竞争本身的损害（prove harm . . . to the competitive process, i.e., to competition itself）”。</p>
<p>少数适用“本身违法”原则的案件中，该等损害可以直接被推定。但是，大部分案件需要经过复杂的分析才能展示竞争损害。传统上，法院会在这些案件中审查市场力量，被告在所定义的相关市场中的份额会在这一过程中起到重要的作用。</p>
<p>当然，市场定义和份额不是决定性的。2010年《水平并购指导方针(Horizontal Merger Guidelines)》中提及了根据特定竞争动态可能进行的几种经济分析。因此，市场以及市场力量应当被视为执法机构用于评估对消费者&#x2F;竞争的损害的工具之一，可以被灵活地运用。</p>
<p>衡量一家企业是否拥有市场力量（market power）需要考虑多个因素：</p>
<ul>
<li>市场份额（Market Share） ：市场份额较大企业一般更多可能具有市场力量，但高市场份额并不是唯一条件。</li>
<li>市场集中度（Market Concentration） ：通过HHI等指标评估整个市场的竞争情况。</li>
<li>进入壁垒（Barriers to Entry） ：如果新进入者难以进入市场，现有企业则更有可能拥有和维持市场力量。</li>
<li>供需弹性（Elasticity of Demand and Supply） ：若需求对价格变化不敏感（价格弹性小），企业较容易实现价格提高。</li>
<li>垄断行为的可能性（Potential for Anticompetitive Conduct） ：企业是否能够通过排除竞争对手或采取其他垄断手段增强其市场力量。</li>
</ul>
<p>案件事实首先对四大医院在不同护理服务类型中的市场份额和收入分布进行了一番介绍。</p>
<p><img src="/../images/Antitrustia/1.png" alt="image-20241126155847205"></p>
<p>从图中可以看出，Alpha医院在初级和二级护理服务方面占有明显优势，而Delta医院在三级护理服务中的收入占比最高。</p>
<p>虽然不清楚市场分布的具体数据，但是可以基于已有的信息计算HHI的最小值。HHI指的是Herfindahl-Hirschman Index，它的增加通常表明行业集中度以及市场力量的增加，下降则相反。</p>
<p>对于初级和二级护理市场，假如市场中只有这四家医院链，那么HHI计算如下：<br>$$<br>HHI&#x3D;40^2+25^2+10^2+5^2&#x3D;2350<br>$$<br>对于三级护理市场：<br>$$<br>HHI&#x3D;10^2+20^2+15^2+35^2&#x3D;1950<br>$$<br>通常，HHI低于1500表示市场竞争度较高，1500到2500之间表示市场中等集中度，超过2500表明市场高集中度。在没有计算其他市场参与者的情况下，初级和二级护理市场以及三级护理市场已经达到了中等集中。</p>
<p>再来看Antitrustia整体的医疗市场：<br>$$<br>HHI&#x3D;30^2+25^2+15^2+10^2&#x3D;1850<br>$$<br>同样处于中度集中。</p>
<p>药品采购市场中，PBMA掌握了60%的市场份额，即使不计算其他市场参与者的份额，也已经达到了市场高度集中。</p>
<p>并且，本案所涉及的医疗领域相对特殊，初级和二级护理市场、三级护理市场、药品采购市场的进入壁垒都较高，需求弹性低，形成垄断的可能性更高。</p>
<table>
<thead>
<tr>
<th align="left">市场</th>
<th align="left">进入壁垒</th>
<th align="left">需求弹性</th>
<th align="left">供应弹性</th>
</tr>
</thead>
<tbody><tr>
<td align="left">整体医疗市场</td>
<td align="left">高资本要求 ：医院和医疗设施的建设和运营需要高额的资本投资。监管要求严格 ：医疗服务提供商需要满足多项法律和卫生标准。</td>
<td align="left">医疗服务和产品的需求往往对价格变化不敏感，主要因为医疗需求的刚性和必要性（特别是紧急和关键医疗服务）。</td>
<td align="left">由于医疗市场的高进入壁垒和长时间的建设、审批及设备采购周期，短期内供应增加的弹性较低。</td>
</tr>
<tr>
<td align="left">初级和二级护理市场</td>
<td align="left">同上</td>
<td align="left">同上</td>
<td align="left">同上</td>
</tr>
<tr>
<td align="left">三级护理市场</td>
<td align="left">高技术需求：专业化设备和高技能医护人员可能涉及到额外的高风险医疗许可研发投入高</td>
<td align="left">需求弹性低：危急重症医疗需求极为刚性</td>
<td align="left">供应弹性低：高技术和资源密集需求</td>
</tr>
<tr>
<td align="left">药品采购市场</td>
<td align="left">规模经济和网络效应：成本和效率优势长期合同和关系：与医院和制造商的长期合作</td>
<td align="left">需求弹性低：基础和关键药物需求刚性大</td>
<td align="left">供应弹性有限：生产受原材料、生产能力和监管限制</td>
</tr>
</tbody></table>
<p>综上，Alpha在初级和二级护理市场具有显著的市场力量，Delta在三级护理市场中具有显著的市场力量，PBMA 在药品采购市场中具有显著市场力量。</p>
<p>由于市场份额达到25%，进入壁垒高，需求弹性小和供应弹性低，Beta 在初级和二级护理市场中具有一定的市场力量，可以影响价格和供应的变化，但非绝对主导力量。同理，Beta在三级护理市场中具备一定市场力量。</p>
<p>考虑到产品差异化和病人忠诚度较低，而且市场份额较低，不认为Gamma在上述市场中具备市场力量。</p>

        
      </div>

         
    </div>
    
     
  </div>
  
    
<nav id="article-nav">
  <a class="article-nav-btn left "
    
      href="/2024/12/17/%E7%BE%8E%E5%9B%BD%E5%8F%8D%E5%9E%84%E6%96%AD%E6%B3%95%E9%9A%8F%E8%AE%B0/"
      title="美国反垄断法随记"
     >
    <i class="fa-solid fa-angle-left"></i>
    <p class="title-text">
      
        美国反垄断法随记
        
    </p>
  </a>
  <a class="article-nav-btn right "
    
      href="/2024/11/23/%E6%88%91%E4%BB%AC%E7%B4%AF%E4%BA%86%20%20%E8%AF%BB%E3%80%8A%E5%80%A6%E6%80%A0%E7%A4%BE%E4%BC%9A%E3%80%8B/"
      title="我们累了 | 读《倦怠社会》 "
     >

    <p class="title-text">
      
        我们累了 | 读《倦怠社会》 
        
    </p>
    <i class="fa-solid fa-angle-right"></i>
  </a>
</nav>


  
</article>


  
  <script src='//unpkg.com/valine/dist/Valine.min.js'></script>
  <div id="comment-card" class="comment-card">
    <div class="main-title-bar">
      <div class="main-title-dot"></div>
      <div class="main-title">Comments </div>
    </div>
    <div id="vcomments"></div>
  </div>
  <script>
      new Valine({"enable":true,"appId":"d11b0rzmnr3P1GXZJHaOnfZg-gzGzoHsz","appKey":"jIiUmjPo1tMCjSeccu3gIDEQ","placeholder":"说点什么~","pageSize":10,"highlight":true,"serverURLs":null,"el":"#vcomments"});
  </script>





    </div>
    <div id="footer-wrapper">
      <footer id="footer">
  
  <div id="footer-info" class="inner">
    
    &copy; 2024 雪糕君<br>
    Powered by <a href="https://hexo.io/" target="_blank">Hexo</a> & Theme <a target="_blank" rel="noopener" href="https://github.com/saicaca/hexo-theme-vivia">Vivia</a>
  </div>
</footer>

    </div>
    <div class="back-to-top-wrapper">
    <button id="back-to-top-btn" class="back-to-top-btn hide" onclick="topFunction()">
        <i class="fa-solid fa-angle-up"></i>
    </button>
</div>

<script>
    function topFunction() {
        window.scroll({ top: 0, behavior: 'smooth' });
    }
    let btn = document.getElementById('back-to-top-btn');
    function scrollFunction() {
        if (document.body.scrollTop > 600 || document.documentElement.scrollTop > 600) {
            btn.classList.remove('hide')
        } else {
            btn.classList.add('hide')
        }
    }
    window.onscroll = function() {
        scrollFunction();
    }
</script>

  </div>
  <script src="/js/light-dark-switch.js"></script>
</body>
</html>
